Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - chlorhexidine gluconate - gel - 0.5 %w/w

Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - chlorhexidine gluconate - cutaneous solution - 0.1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - chlorhexidine gluconate - cutaneous solution - 1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - lidocaine hydrochloride zinc oxide bismuth oxide benzoic acid cinnamic acid - cream - 25 grams

Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - chlorhexidine gluconate - gel - 0.5 %w/w

Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - chlorhexidine gluconate - cutaneous solution - 0.1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - chlorhexidine gluconate - cutaneous solution - 1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

eastern pharmaceuticals limited - lidocaine hydrochloride zinc oxide bismuth oxide benzoic acid cinnamic acid - cream - 25 grams

United States - English - NLM (National Library of Medicine)

macleods pharmaceuticals limited - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tramadol hydrochloride 37.5 mg - tramadol hydrochloride and acetaminophen tablets are indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use tramadol hydrochloride and acetaminophen tablets are indicated for short-term use of five days or less. because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1], reserve tramadol hydrochloride and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: • have not been tolerated, or are not expected to be tolerated, • have not provided adequate analgesia, or are not expected to provide adequate analgesia. tramadol hydrochloride and acetaminophen is contraindicated for: • all children younger than 12 years of age [see warnings and precautions ( 5.4 ) ] • post-operative management in children younger than 18 years of age following tonsillectomy and

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals limited - nitrofurantoin (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - nitrofurantoin capsules, usp (macrocrystals) is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli, enterococci, staphylococcus aureus , and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin capsules, usp (macrocrystals) and other antibacterial drugs, nitrofurantoin capsules, usp (macrocrystals) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distributio